BIOMEDICAL ENGINEERING CONCEPT
A patient-carried DNA archive
An encrypted digital copy of a patient’s genome—encoded in synthetic DNA, sealed inside a removable subdermal capsule, and retrieved through a targeted lab-on-a-chip reader.
Synthetic storage DNA. No chromosome editing.
Concept proposal · Not clinically validated
SKIN SURFACE
Passive capsule · protected synthetic-DNA beads
EXTERNAL READER
Separate disposable microfluidic cartridge
Three kinds of DNA must stay separate
The proposal works only when the biological genome, its digital representation, and the synthetic storage molecule are treated as different systems.
Patient genome
Living chromosomes inside the patient’s cells. This is the biological source and is never edited by the storage system.
Digital genome
A sequenced, compressed, and encrypted computer file representing the patient’s DNA and selected medical records.
Storage DNA
Manufactured, nonliving DNA strands that encode the digital file using combinations of A, C, G, and T.
DNA is cold storage—not a fast hard drive
Synthetic DNA is being researched because it offers exceptional information density, does not require electrical power while stored, and may remain stable for long archival periods under controlled conditions. These archival figures have not been demonstrated inside the human body.
Up to approximately 1 EB/mm³
Theoretical raw storage density cited by Microsoft Research.
More than 500 years
Observed DNA half-life referenced in archival-storage research.
Critical caveat
The main speed bottleneck is not the capsule. It is file selection, amplification, sequencing, error correction, and decoding.
Fast access starts with a small clinical layer
Tier 1 — Emergency manifest
Identity token, allergies, medications, critical diagnoses, consent, record version, and secure retrieval instructions.
Tier 2 — Actionable genomic panel
Pharmacogenomic markers, disease-relevant variants, and clinician-selected records.
Tier 3 — Full archive
A compressed whole-genome record, provenance information, checksums, and optional cold medical files.
Writing happens once, outside the body
01
Sequence
Create verified genome and clinical files.
02
Protect
Compress, encrypt, and digitally sign the information.
03
Encode
Add file indexes, strand addresses, and error-correction data.
04
Synthesize
Manufacture short, nonliving DNA strands.
05
Encapsulate
Seal or bind the strands inside protected, retrievable beads.
06
Load
Place the DNA beads inside a removable, serialized capsule.
Security requirement
Keep the private decryption key separate from the physical capsule.
A passive capsule still requires a physical sample
The implant would contain no battery, wireless transmitter, or electronic memory. A sterile micro-sample would have to be physically removed because archived DNA cannot be read noninvasively through the skin.
SKIN SURFACE
Disposable reader cartridge
External · microfluidic · physically sampled
Inert removable housing
Protected DNA-bead reservoir
Proposed self-sealing port
External disposable cartridge
The access-port design is proposed and unvalidated. Repeated sterile sampling, sealing performance, migration, wear, and infection risk would require dedicated testing.
The reader automates six retrieval stages
Authorize
Verify consent and choose the requested information tier.
Sample
Withdraw a sterile micro-droplet from the capsule.
Capture
Use magnetic handling to isolate and wash the DNA beads.
Select
Use file-specific primers to amplify the requested file family.
Sequence
Load the enriched DNA into a portable nanopore sequencer.
Decode
Stream the reads, correct errors, verify authenticity, and decrypt the file.
The most defensible prototype should validate file-selective PCR first. Isothermal amplification should be treated as a later optimization rather than an established feature.
Index tags retrieve one file at a time
START TAG
PAYLOAD FRAGMENTS + STRAND ADDRESSES
END TAG
Primer addresses select a file family before sequencing. Strand addresses and error-correcting codes then reconstruct the original digital file.
Tag-design rules
• Use distinct primer sequences with strong mutual separation. • Maintain balanced GC content and similar melting behavior. • Avoid long homopolymers and strong self-hairpins. • Screen for primer-to-payload collisions experimentally. • Do not claim that cross-reactions can be eliminated completely.
A 2018 Nature Biotechnology study demonstrated individual recovery of 35 files totaling more than 200 MB from a pool containing more than 13 million DNA oligonucleotides.
A clinical summary can arrive before the full genome
Emergency manifest
Single indexed micro-file
Engineering target of tens of minutes
Actionable variant panel
Targeted file family
Depends on target size and required coverage
Whole-genome archive
Many files and strand groups
Hours or longer
Large imaging archive
Extremely fragmented payload
Not appropriate for urgent access
Nanopore sequencers can stream reads in real time once sequencing begins, but sample preparation and sufficient coverage still determine total turnaround time. ‘Tens of minutes’ is a design target, not a demonstrated clinical result.
The parts exist; the implanted system does not
Demonstrated components
• Digital files have been stored and recovered from synthetic DNA. • Primers have retrieved selected files from large DNA pools. • Silica has protected DNA in laboratory aging studies. • Portable nanopore sequencing provides real-time data. • Automated microfluidic DNA preparation has been demonstrated.
Proposed integration
• Long-term DNA stability inside the human body • Repeated sterile sampling from a tiny capsule • Reliable end-to-end targeted retrieval • Safe replacement when records change • Clinical usability and regulatory approval
This project is an integration hypothesis—not a claim that an implantable DNA drive already exists.
Safety requires removability, redundancy, and consent
Physical safety
• Passive and removable construction • No genome integration or wireless transmitter • Biocompatible housing • Migration control • Leak, wear, infection, and repeated-access testing • An external backup so the implant is never the only copy
Data safety
• Encryption before molecular encoding • A decryption key stored separately • Signed manifests and integrity checks • Patient consent and role-based access • Access logging • Record revocation and replacement • Protection against outdated clinical information
Privacy warning
Genomic data may reveal health information, traits, and biological relationships. Ordinary medical-record protections may not be sufficient.
Prototype outside the body first
Phase 1
Benchtop archive
Encode a small clinical record, retrieve indexed files, and measure error rate and repeatability.
Phase 2
Integrated cartridge
Automate bead handling, amplification, nanopore reading, authentication, and decoding.
Phase 3
Biological evaluation
Use inert dummy payloads to test housing, sealing, tissue response, migration, and removal. Do not begin with human genomic data or human implantation.
Advance only after retrieval reliability, contamination control, biocompatibility, and privacy meet predefined acceptance criteria.
Build a removable archive before an implant
The credible first system is a patient-controlled, encrypted DNA cartridge with a rapid targeted reader. Implantation should be considered only after the archive and reader work reliably outside the body.
Archive
Synthetic DNA offers density and offline durability.
Prioritize
A small emergency layer is retrieved before the complete genome.
Validate
Safety, sterility, reliability, and privacy are core product requirements.